Nitric oxide and disorders of the erythrocyte: Emerging roles and therapeutic targets

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 10, Issue 4, 2010, Pages 284-291

  Maley, Jason H ^a   Lasker, George F ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Banked blood; Erythrocyte; Hemoglobin; Malaria; Nitric oxide; Sickle cell disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; DEOXYHEMOGLOBIN; HEMOGLOBIN; NITRIC OXIDE; NITRITE REDUCTASE; S NITROSOHEMOGLOBIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BANK; BLOOD VESSEL TONE; ERYTHROCYTE DISORDER; HUMAN; MALARIA; NONHUMAN; SICKLE CELL ANEMIA;

EID: 79953842951     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152910793743878     Document Type: Article

References (86)

1. Wintrobe, M.M. Blood, pure and eloquent: A Story of Discovery, of People, and of Ideas, McGraw-Hill: New York, 1980; p. xxii, 771.
2. Hünefeld, F.L. Die Chemismus in der thierischen Organization. Leipzig, 1840.
3. Funke, O., Ueber das Milzvenenblut. Zeitschrift fur rationelle Medizin., 1851, 1, 172-177.
4. Poskitt, E.M. Early history of iron deficiency. Br. J. Haematol., 2003, 122(4), 554-562.
5. Bohr, C.; Hasselbalch, K.; Krogh, A. Ueber einen in biologischer Beziehung wichtigen Einfluss, den die Kohlensaurespannung des Blutes auf dessen Sauerstoffbindung ubt. Skand. Arch. Physiol., 1904, 16, 402.
6. Antonini, E.; Brunori, M.; Wyman, J.; Noble, R.W. Preparation and kinetic properties of intermediates in the reaction of hemoglobin with ligands. J. Biol. Chem., 1966, 241(13), 3236-3238.
7. Gibson, W.H.; Roughton, F.J. The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J. Physiol., 1957, 136(3), 507-524.
8. Ellsworth, M.L.; Forrester, T.; Ellis, C.G.; Dietrich, H.H. The erythrocyte as a regulator of vascular tone. Am. J. Physiol., 1995, 269(6 Pt 2), H2155-H2161.
9. Bergfeld, G.R.; Forrester, T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc. Res., 1992, 26(1), 40-47.
10. Light, D.B.; Capes, T.L.; Gronau, R.T.; Adler, M.R. Extracellular ATP stimulates volume decrease in Necturus red blood cells. Am. J. Physiol., 1999, 277(3 Pt 1), C480-C491.
11. Campanella, M.E.; Chu, H.; Low, P.S. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc. Natl. Acad. Sci. USA, 2005, 102(7), 2402-2407.
12. Jagger, J.E.; Bateman, R.M.; Ellsworth, M.L.; Ellis, C.G. Role of erythrocyte in regulating local O2 delivery mediated by hemoglobin oxygenation. Am. J. Physiol. Heart Circ. Physiol., 2001, 280(6), H2833-H2839.
13. Sprague, R.S.; Ellsworth, M.L.; Stephenson, A.H.; Lonigro, A.J. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am. J. Physiol., 1996, 271 (6 Pt 2), H2717-H2722.
14. Schwiebert, E.M.; Zsembery, A. Extracellular ATP as a signaling molecule for epithelial cells. BiochimI. Biophys. Acta., 2003, 1615(1-2), 7-32.
15. Ellsworth, M.L. The red blood cell as an oxygen sensor: what is the evidence? Acta Physiol. Scand., 2000, 168(4), 551-559.
16. Kleinbongard, P.; Schulz, R.; Rassaf, T.; Lauer, T.; Dejam, A.; Jax, T.; Kumara, I.; Gharini, P.; Kabanova, S.; Ozuyaman, B.; Schnurch, H. G.; Godecke, A.; Weber, A. A.; Robenek, M.; Robenek, H.; Bloch, W.; Rosen, P.; Kelm, M. Red blood cells express a functional endothelial nitric oxide synthase. Blood, 2006, 107(7), 2943-2951.
17. Gladwin, M.T. Does eNOS stand for erythrocytic NO synthase? Blood, 2006, 107, 2595-2596.
18. Hilarius, P.M.; Goedhart, P.T.; Ince, C.; Verhoeven, A.J. Human erythrocytes contain negligible amounts of endothelial type NO synthase (eNOS). Abstracts of the Second International Meeting of the Role of Nitrite in Physiology Pathophysiol Therapeut. 2007, 90-91.
19. Jensen, F.B. The dual roles of red blood cells in tissue oxygen delivery: oxygen carriers and regulators of local blood flow. J. Exp. Biol., 2009, 212(Pt 21), 3387-3393.
20. Jia, L.; Bonaventura, C.; Bonaventura, J.; Stamler, J.S. Snitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature, 1996, 380(6571), 221-226.
21. Stamler, J.S.; Jia, L.; Eu, J P.; McMahon, T J.; Demchenko, I.T.; Bonaventura, J.; Gernert, K.; Piantadosi, C.A. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science, 1997, 276(5321), 2034-2037.
22. Cosby, K.; Partovi, K.S.; Crawford, J.H.; Patel, R.P.; Reiter, C.D.; Martyr, S.; Yang, B.K.; Waclawiw, M.A.; Zalos, G.; Xu, X.; Huang, K.T.; Shields, H.; Kim-Shapiro, D.B.; Schechter, A.N.; Cannon, R.O., 3rd; Gladwin, M. T., Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med., 2003, 9 (12), 1498-1505.
23. Kim-Shapiro, D.B.; Schechter, A.N.; Gladwin, M.T. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler. Thromb. Vasc. Biol., 2006, 26(4), 697-705.
24. Pawloski, J.R.; Hess, D.T.; Stamler, J.S. Export by red blood cells of nitric oxide bioactivity. Nature, 2001, 409(6820), 622-626.
25. Sonveaux, P.; Lobysheva, II; Feron, O.; McMahon, T.J. Transport and peripheral bioactivities of nitrogen oxides carried by red blood cell hemoglobin: role in oxygen delivery. Physiology(Bethesda), 2007, 22, 97-112.
26. McMahon, T.J.; Ahearn, G.S.; Moya, M.P.; Gow, A.J.; Huang, Y.C.; Luchsinger, B.P.; Nudelman, R.; Yan, Y.; Krichman, A.D.; Bashore, T.M.; Califf, R.M.; Singel, D.J.; Piantadosi, C.A.; Tapson, V.F.; Stamler, J.S. A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc. Natl. Acad. Sci. USA, 2005, 102(41), 14801-14806.
27. Gladwin, M.T.; Lancaster, J.R., Jr.; Freeman, B.A.; Schechter, A.N. Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nat. Med., 2003, 9(5), 496-500.
28. Isbell, T.S.; Sun, C.W.; Wu, L.C.; Teng, X.; Vitturi, D.A.; Branch, B.G.; Kevil, C.G.; Peng, N.; Wyss, J.M.; Ambalavanan, N.; Schwiebert, L.; Ren, J.; Pawlik, K.M.; Renfrow, M.B.; Patel, R.P.; Townes, T. M., SNO-hemoglobin is not essential for red blood celldependent hypoxic vasodilation. Nat. Med., 2008, 14(7), 773-777.
29. Stamler, J.S.; Singel, D.J.; Piantadosi, C.A. SNO-hemoglobin and hypoxic vasodilation. Nat. Med., 2008, 14(10), 1008-9; author reply 1009-1010.
30. Shiva, S.; Wang, X.; Ringwood, L. A.; Xu, X.; Yuditskaya, S.; Annavajjhala, V.; Miyajima, H.; Hogg, N.; Harris, Z.L.; Gladwin, M.T. Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat. Chem. Biol., 2006, 2(9), 486-493.
31. Gladwin, M.T.; Kim-Shapiro, D.B. The functional nitrite reductase activity of the heme-globins. Blood, 2008, 112(7), 2636-2647.
32. Mellion, B.T.; Ignarro, L.J.; Ohlstein, E H.; Pontecorvo, E.G.; Hyman, A.L.; Kadowitz, P.J. Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood, 1981, 57(5), 946-955.
33. Basu, S.; Grubina, R.; Huang, J.; Conradie, J.; Huang, Z.; Jeffers, A.; Jiang, A.; He, X.; Azarov, I.; Seibert, R.; Mehta, A.; Patel, R.; King, S.B.; Hogg, N.; Ghosh, A.; Gladwin, M.T.; Kim-Shapiro, D. B. Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin. Nat. Chem. Biol., 2007, 3(12), 785-794.
34. Shiva, S.; Huang, Z.; Grubina, R.; Sun, J.; Ringwood, L.A.; MacArthur, P.H.; Xu, X.; Murphy, E.; Darley-Usmar, V.M.; Gladwin, M.T. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ. Res., 2007, 100(5), 654-661.
35. Crawford, J.H.; Isbell, T.S.; Huang, Z.; Shiva, S.; Chacko, B.K.; Schechter, A.N.; Darley-Usmar, V.M.; Kerby, J.D.; Lang, J.D., Jr.; Kraus, D.; Ho, C.; Gladwin, M.T.; Patel, R.P. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood, 2006, 107(2), 566-574.
36. Casey, D.B.; Badejo, A.M., Jr.; Dhaliwal, J.S.; Murthy, S.N.; Hyman, A.L.; Nossaman, B.D.; Kadowitz, P.J. Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat. Am. J. Physiol. Heart Circ. Physiol., 2009, 296(2), H524-H533.
37. Golwala, N.H.; Hodenette, C.; Murthy, S.N.; Nossaman, B.D.; Kadowitz, P.J. Vascular responses to nitrite are mediated by xanthine oxidoreductase and mitochondrial aldehyde dehydrogenase in the rat. Can. J. Physiol. Pharmacol., 2009, 87(12), 1095-1101.
38. Badejo, A.M., Jr.; Hodnette, C.M.; Dhaliwal, J.S.; Casey, D.B.; Pankey, E.A.; Murthy, S.N.; Nossaman, B.D.; Hyman, A.L.; Kadowitz, P.J. Mitochondrial Aldehyde Dehydrogenase Mediates Vasodilator Responses of Glyceryl Trinitrate and Sodium Nitrite in the Pulmonary Vascular Bed of the Rat. Am. J. Physiol. Heart Circ. Physiol., 2010, 299(3), H819-H826.
39. Gladwin, M.T.; Vichinsky, E. Pulmonary complications of sickle cell disease. N. Engl. J. Med. 2008, 359(21), 2254-2265.
40. Wood, K.C.; Hsu, L.L.; Gladwin, M.T. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic. Biol. Med., 2008, 44(8), 1506-1528.
41. Bensinger, T.A.; Gillette, P.N. Hemolysis in sickle cell disease. Arch. Intern. Med., 1974, 133(4), 624-631.
42. Reiter, C.D.; Wang, X.; Tanus-Santos, J.E.; Hogg, N.; Cannon, R.O., 3rd; Schechter, A.N.; Gladwin, M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med., 2002, 8(12), 1383-1389.
43. Kato, G.J.; Hebbel, R.P.; Steinberg, M.H.; Gladwin, M.T. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am. J. Hematol., 2009, 84(9), 618-625.
44. Morris, C.R.; Kato, G.J.; Poljakovic, M.; Wang, X.; Blackwelder, W.C.; Sachdev, V.; Hazen, S. L.; Vichinsky, E.P.; Morris, S.M., Jr.; Gladwin, M.T. Dysregulated arginine metabolism, hemolysisassociated pulmonary hypertension, and mortality in sickle cell disease. JAMA, 2005, 294(1), 81-90.
45. Panza, J.A.; Casino, P.R.; Kilcoyne, C.M.; Quyyumi, A.A. Role of endothelium-derived nitric oxide in the abnormal endotheliumdependent vascular relaxation of patients with essential hypertension. Circulation, 1993, 87(5), 1468-1474.
46. Space, S.L.; Lane, P.A.; Pickett, C.K.; Weil, J.V. Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium. Am. J. Hematol., 2000, 63(4), 200-204.
47. De Caterina, R.; Libby, P.; Peng, H.B.; Thannickal, V.J.; Rajavashisth, T.B.; Gimbrone, M.A., Jr.; Shin, W.S.; Liao, J. K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest., 1995, 96(1), 60-68.
48. Bunn, H.F.; Nathan, D.G.; Dover, G.J.; Hebbel, R.P.; Platt, O.S.; Rosse, W.F.; Ware, R.E. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood, 2010, 116(5), 687-692.
49. Gladwin, M.T.; Sachdev, V.; Jison, M.L.; Shizukuda, Y.; Plehn, J.F.; Minter, K.; Brown, B.; Coles, W.A.; Nichols, J.S.; Ernst, I.; Hunter, L.A.; Blackwelder, W.C.; Schechter, A.N.; Rodgers, G.P.; Castro, O.; Ognibene, F.P. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med., 2004, 350(9), 886-895.
50. Reiter, C.D.; Gladwin, M.T. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr. Opin. Hematol., 2003, 10(2), 99-107.
51. Oppert, M.; Jorres, A.; Barckow, D.; Eckardt, K.U.; Frei, U.; Kaisers, U. Inhaled nitric oxide for ARDS due to sickle cell disease. Swiss. Med. Wkly., 2004, 134(11-12), 165-167.
52. Montero-Huerta, P.; Hess, D. R.; Head, C. A., Inhaled nitric oxide for treatment of sickle cell stroke. Anesthesiology, 2006, 105(3), 619-621.
53. Weiner, D.L.; Hibberd, P.L.; Betit, P.; Cooper, A.B.; Botelho, C.A.; Brugnara, C. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA, 2003, 289(9), 1136-1142.
54. Kappe, S.H.; Vaughan, A.M.; Boddey, J.A.; Cowman, A.F. That was then but this is now: malaria research in the time of an eradication agenda. Science, 2010, 328, 862-866.
55. Sobolewski, P.; Gramaglia, I.; Frangos, J.; Intaglietta, M.; van der Heyde, H.C. Nitric oxide bioavailability in malaria. Trends Parasitol., 2005, 21(9), 415-522.
56. White, N.J. The treatment of malaria. N. Engl. J. Med., 1996, 335(11), 800-806.
57. Weinberg, J.B.; Lopansri, B.K.; Mwaikambo, E.; Granger, D.L. Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr. Opin. Infect Dis., 2008, 21(5), 468-475.
58. Clark, I.A.; Rockett, K.A.; Cowden, W.B. Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol. Today, 1991, 7(8), 205-207.
59. Weiss, G.; Thuma, P. E.; Biemba, G.; Mabeza, G.; Werner, E. R.; Gordeuk, V.R. Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. J. Infect. Dis., 1998, 177(4), 1064-1068.
60. Gramaglia, I.; Sobolewski, P.; Meays, D.; Contreras, R.; Nolan, J.P.; Frangos, J.A.; Intaglietta, M.; van der Heyde, H.C. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat. Med., 2006, 12(12), 1417-1422.
61. Turner, G. D.; Morrison, H.; Jones, M.; Davis, T. M.; Looareesuwan, S.; Buley, I. D.; Gatter, K. C.; Newbold, C. I.; Pukritayakamee, S.; Nagachinta, B.; White, N.J.; Berendt, A.R. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 1994, 145 (5), 1057-1069.
62. Anstey, N.M.; Weinberg, J.B.; Hassanali, M.Y.; Mwaikambo, E.D.; Manyenga, D.; Misukonis, M.A.; Arnelle, D.R.; Hollis, D.; McDonald, M.I.; Granger, D.L. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med., 1996, 184(2), 557-567.
63. Lopansri, B.K.; Anstey, N.M.; Weinberg, J.B.; Stoddard, G.J.; Hobbs, M.R.; Levesque, M.C.; Mwaikambo, E.D.; Granger, D.L. Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet, 2003, 361(9358), 676-678.
64. Yeo, T.W.; Lampah, D.A.; Gitawati, R.; Tjitra, E.; Kenangalem, E.; McNeil, Y.R.; Darcy, C.J.; Granger, D.L.; Weinberg, J.B.; Lopansri, B.K.; Price, R.N.; Duffull, S.B.; Celermajer, D.S.; Anstey, N. M. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J. Exp. Med., 2007, 204(11), 2693-2704.
65. Yeo, T.W.; Lampah, D.A.; Tjitra, E.; Gitawati, R.; Darcy, C.J.; Jones, C.; Kenangalem, E.; McNeil, Y.R.; Granger, D.L.; Lopansri, B.K.; Weinberg, J.B.; Price, R.N.; Duffull, S.B.; Celermajer, D. S.; Anstey, N.M. Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog., 2010, 6(4), e1000868.
66. Fan, Q.; Miao, J.; Cui, L. Characterization of PRMT1 from Plasmodium falciparum. Biochem. J., 2009, 421(1), 107-118.
67. Richir, M.C.; Bouwman, R.H.; Teerlink, T.; Siroen, M.P.; de Vries, T.P.; van Leeuwen, P.A. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function. JPEN J. Parenter Enteral. Nutr., 2008, 32 (6), 613-621.
68. Teerlink, T. ADMA metabolism and clearance. Vasc. Med., 2005, 10(1), S73-S81.
69. Bishop, C.W.; Surgenor, D.M. The Red Blood Cell; A Comprehensive Treatise, Academic Press: New York, 1964; p xiv, 566 p.
70. Loutit, J.F.; Mollison, P.L. Advantages of a disodium-citrateglucose mixture as a blood preservative. Brit. J. Med., 1943, 2, 744.
71. Tinmouth, A.; Fergusson, D.; Yee, I. C.; Hebert, P. C., Clinical consequences of red cell storage in the critically ill. Transfusion, 2006, 46(11), 2014-2027.
72. Hess, J.R.; Greenwalt, T.G. Storage of red blood cells: new approaches. Transfus. Med. Rev., 2002, 16(4), 283-295.
73. Petz, L.D.; Swisher, S.N. Clinical Practice of Transfusion Medicine. 2nd ed.; Churchill Livingstone: New York, 1989; p xiii, 790 p.
74. Valeri, C.R.; Pivacek, L.E.; Cassidy, G.P.; Ragno, G. The survival, function, and hemolysis of human RBCs stored at 4 degrees C in additive solution (AS-1, AS-3, or AS-5) for 42 days and then biochemically modified, frozen, thawed, washed, and stored at 4 degrees C in sodium chloride and glucose solution for 24 hours. Transfusion, 2000, 40(11), 1341-1345.
75. Whitaker, B.; Sullivan, M. The 2005 Nationwide Blood Collection and Utilization Survery Report; AABB: Bethesda, MD, 2005.
76. Leal-Noval, S.R.; Rincon-Ferrari, M.D.; Garcia-Curiel, A.; Herruzo-Aviles, A.; Camacho-Larana, P.; Garnacho-Montero, J.; Amaya-Villar, R. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest, 2001, 119(5), 1461-1468.
77. Zallen, G.; Offner, P.J.; Moore, E.E.; Blackwell, J.; Ciesla, D. J.; Gabriel, J.; Denny, C.; Silliman, C.C. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am. J. Surg., 1999, 178(6), 570-572.
78. Koch, C.G.; Li, L.; Sessler, D.I.; Figueroa, P.; Hoeltge, G.A.; Mihaljevic, T.; Blackstone, E.H. Duration of red-cell storage and complications after cardiac surgery. N. Engl. J. Med., 2008, 358(12), 1229-1239.
79. van de Watering, L.; Lorinser, J.; Versteegh, M.; Westendord, R.; Brand, A. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion, 2006, 46(10), 1712-1718.
80. Hess, J. R., Red cell storage. J. Proteomics, 73 (3), 368-373.
81. Bennett-Guerrero, E.; Veldman, T.H.; Doctor, A.; Telen, M.J.; Ortel, T.L.; Reid, T.S.; Mulherin, M.A.; Zhu, H.; Buck, R D.; Califf, R.M.; McMahon, T.J. Evolution of adverse changes in stored RBCs. Proc. Natl. Acad. Sci. USA, 2007, 104(43), 17063-17068.
82. Reynolds, J.D.; Ahearn, G.S.; Angelo, M.; Zhang, J.; Cobb, F.; Stamler, J.S. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc. Natl. Acad. Sci. USA, 2007, 104(43), 17058-17062.
83. Gladwin, M.T.; Kim-Shapiro, D.B. Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis. Curr. Opin. Hematol., 2009, 16(6), 515-523.
84. Yoshida, T.; AuBuchon, J. P.; Tryzelaar, L.; Foster, K.Y.; Bitensky, M.W. Extended storage of red blood cells under anaerobic conditions. Vox Sang, 2007, 92(1), 22-31.
85. D'Amici, G.M.; Rinalducci, S.; Zolla, L. Proteomic analysis of RBC membrane protein degradation during blood storage. J. Proteome Res., 2007, 6(8), 3242-3255.
86. Yoshida, T.; AuBuchon, J.P.; Dumont, L.J.; Gorham, J.D.; Gifford, S.C.; Foster, K.Y.; Bitensky, M. W., The effects of additive solution pH and metabolic rejuvenation on anaerobic storage of red cells. Transfusion, 2008, 48(10), 2096-2105.